Personal information

Other IDs

Scopus Author ID: 56565917800
ResearcherID: ABF-9058-2022
Researcher Name Resolver ID: 1000030791553

Countries

Japan

Biography

2022- Chiba University
2020- RIKEN
2019- Teikyo University Chiba Medical Center

Activities

Collapse all

Employment (1)

Chiba University: Chiba, JP

2022-04-01 to present
Employment
Source: Self-asserted source
Takahiro Aoki

Education and qualifications (1)

Graduate School of Medicine, Chiba University: Chiba, JP

2015-04-01 to 2019-03-31
Education
Source: Self-asserted source
Takahiro Aoki

Works (24)

Antibody‐Dependent Cellular Cytotoxicity of iPS Cell‐Derived Natural Killer T Cells by Anti‐GD2 mAb for Neuroblastoma

Cancer Science
2025-02-06 | Journal article
DOI: 10.1111/cas.70008
Contributors: Katsuhiro Nishimura; Takahiro Aoki; Midori Kobayashi; Mariko Takami; Ko Ozaki; Keita Ogawa; Wang Hongxuan; Daiki Shimizu; Daisuke Katsumi; Hiroko Yoshizawa et al.
Source: check_circle
Crossref

Effectiveness of isavuconazole in invasive cerebral aspergillosis during hematopoietic stem cell transplantation in a pediatric patient with myelodysplastic syndrome: A case report

Journal of Infection and Chemotherapy
2025-01 | Journal article
DOI: 10.1016/j.jiac.2024.07.018
Contributors: Hajime Nemoto; Moeko Hino; Takahiro Aoki; Yoshiharu Yamashita; Tomoko Okunushi; Koo Nagasawa; Naruhiko Ishiwada; Akira Watanabe; Shingo Yamazaki; Hiromichi Hamada
Source: check_circle
Crossref

High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor

Pediatric Blood & Cancer
2024-02 | Journal article
DOI: 10.1002/pbc.30803
Contributors: Takahiro Aoki; Norio Shiba; Shinichi Tsujimoto; Genki Yamato; Yusuke Hara; Shota Kato; Kenichi Yoshida; Seishi Ogawa; Yasuhide Hayashi; Shotaro Iwamoto et al.
Source: check_circle
Crossref

Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner

Cancer Research Communications
2024-02-19 | Journal article
DOI: 10.1158/2767-9764.CRC-23-0203
Contributors: Mariko Takami; Takahiro Aoki; Katsuhiro Nishimura; Hidekazu Tanaka; Atsushi Onodera; Shinichiro Motohashi
Source: check_circle
Crossref

Progresses in NKT cell-based immunotherapy for cancers: Use of allogeneic and gene-edited cells

Critical Reviews™ in Oncogenesis
2023 | Journal article
DOI: 10.1615/critrevoncog.2023049526
Part of ISSN: 0893-9675
Contributors: Takahiro Aoki; Shinichiro Motohashi
Source: Self-asserted source
Takahiro Aoki

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy

Inflammation and Regeneration
2023-05-12 | Journal article | Author
DOI: 10.1186/s41232-023-00275-5
Part of ISSN: 1880-8190
Contributors: Takahiro Aoki; Shinichiro Motohashi; Haruhiko Koseki
Source: Self-asserted source
Takahiro Aoki
grade
Preferred source (of 2)‎

A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20)

Japanese Journal of Clinical Oncology
2022-07-09 | Journal article
DOI: 10.1093/jjco/hyac105
Part of ISSN: 1465-3621
Contributors: Daisuke Tomizawa; Shin-ichi Tsujimoto; Shiro Tanaka; Jun Matsubayashi; Takahiro Aoki; Shotaro Iwamoto; Daisuke Hasegawa; Kozo Nagai; Kentaro Nakashima; Koji Kawaguchi et al.
Source: Self-asserted source
Takahiro Aoki

Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study

British Journal of Haematology
2021 | Journal article
DOI: 10.1111/bjh.16656
EID:

2-s2.0-85084120573

Part of ISSN: 13652141 00071048
Contributors: Aoki, T.; Takahashi, H.; Tanaka, S.; Shiba, N.; Hasegawa, D.; Iwamoto, S.; Terui, K.; Moritake, H.; Nakayama, H.; Shimada, A. et al.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 3)‎

Chronic-phase chronic myeloid leukemia with intracranial hemorrhage complicated with tumor lysis syndrome.

[Rinsho ketsueki] The Japanese journal of clinical hematology
2021-01-01 | Journal article
DOI: 10.11406/rinketsu.62.346
PMID: 34108312
Contributors: Oyama C; Arakawa Y; Ikeda Y; Aoki T; Kubota Y; Isobe K; Mori M; Kurihara J; Koh K
Source: Self-asserted source
Takahiro Aoki

A 21-Month-Old Boy with One-Month History of Vomiting

Brain Pathology
2020 | Journal article
DOI: 10.1111/bpa.12823
EID:

2-s2.0-85080082227

Part of ISSN: 17503639 10156305
Contributors: Aoki, T.; Kishimoto, H.; Hirato, J.; Kanemura, Y.; Mori, M.; Arakawa, Y.; Kurihara, J.; Oguma, E.; Koh, K.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner

Cancer Science
2020 | Journal article
DOI: 10.1111/cas.14428
EID:

2-s2.0-85087177491

Part of ISSN: 13497006 13479032
Contributors: Aoki, T.; Takami, M.; Takatani, T.; Motoyoshi, K.; Ishii, A.; Hara, A.; Toyoda, T.; Okada, R.; Hino, M.; Koyama-Nasu, R. et al.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 3)‎

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy

Cancer Immunology, Immunotherapy
2020 | Journal article
DOI: 10.1007/s00262-020-02742-1
EID:

2-s2.0-85094669012

Part of ISSN: 14320851 03407004
Contributors: Hara, A.; Koyama-Nasu, R.; Takami, M.; Toyoda, T.; Aoki, T.; Ihara, F.; Kobayashi, M.; Hirono, S.; Matsutani, T.; Nakayama, T. et al.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Successful management of acute chest syndrome in a patient with sickle cell disease.

[Rinsho ketsueki] The Japanese journal of clinical hematology
2019-01-01 | Journal article
DOI: 10.11406/rinketsu.60.382
PMID: 31167999
Contributors: Kubota Y; Arakawa Y; Watanabe K; Ikeda Y; Oyama C; Aoki T; Isobe K; Mori M; Hanada R; Koh K
Source: Self-asserted source
Takahiro Aoki

Macrothrombocytopenia with Congenital Bilateral Cataracts: A Phenotype of MYH9 Disorder with Exon 24 Indel Mutations

Journal of Pediatric Hematology/Oncology
2018 | Journal article
DOI: 10.1097/MPH.0000000000000998
EID:

2-s2.0-85042365414

Part of ISSN: 15363678 10774114
Contributors: Aoki, T.; Kunishima, S.; Yamashita, Y.; Minamitani, K.; Ota, S.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Programmed Death Ligand 1 Expression in Classical Hodgkin Lymphoma in Pediatric Patients

Journal of Pediatric Hematology/Oncology
2018 | Journal article
DOI: 10.1097/MPH.0000000000001030
EID:

2-s2.0-85040358003

Part of ISSN: 15363678 10774114
Contributors: Aoki, T.; Kyushiki, M.; Kishimoto, H.; Yanagi, M.; Mori, M.; Arakawa, Y.; Hino, M.; Shimojo, N.; Koh, K.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Transurethral resection for botryoid bladder rhabdomyosarcoma

Journal of Pediatric Surgery Case Reports
2018 | Journal article
DOI: 10.1016/j.epsc.2017.09.009
EID:

2-s2.0-85030678809

Part of ISSN: 22135766
Contributors: Nakata, M.; Hishiki, T.; Sakurai, H.; Saito, T.; Terui, K.; Mitsunaga, T.; Komatsu, S.; Ochiai, H.; Hino, M.; Ando, K. et al.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children

Leukemia
2017 | Journal article
DOI: 10.1038/leu.2016.274
EID:

2-s2.0-84992380016

Part of ISSN: 14765551 08876924
Contributors: Kato, M.; Ishimaru, S.; Seki, M.; Yoshida, K.; Shiraishi, Y.; Chiba, K.; Kakiuchi, N.; Sato, Y.; Ueno, H.; Tanaka, H. et al.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Reversible Cerebral Vasoconstriction Syndrome during Chemotherapy for Acute Lymphoblastic Leukemia

Journal of Pediatrics
2017 | Journal article
DOI: 10.1016/j.jpeds.2016.09.045
EID:

2-s2.0-85005950724

Part of ISSN: 10976833 00223476
Contributors: Aoki, T.; Koh, K.; Arakawa, Y.; Mori, M.; Oguma, E.; Hanada, R.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review

Biology of Blood and Marrow Transplantation
2016 | Journal article
DOI: 10.1016/j.bbmt.2016.05.021
EID:

2-s2.0-84979643826

Part of ISSN: 15236536 10838791
Contributors: Aoki, T.; Koh, K.; Ikeda, Y.; Sekinaka, Y.; Akiyama, K.; Mori, M.; Arakawa, Y.; Hanada, R.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Erythematous Plaques in a Child with Sweet Syndrome

Journal of Pediatrics
2016 | Journal article
DOI: 10.1016/j.jpeds.2016.05.055
EID:

2-s2.0-85006355897

Part of ISSN: 10976833 00223476
Contributors: Aoki, T.; Yamashita, Y.; Minamitani, K.; Ota, S.; Hayakawa, K.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers

Pediatric Blood and Cancer
2016 | Journal article
DOI: 10.1002/pbc.26018
EID:

2-s2.0-84976487722

Part of ISSN: 15455017 15455009
Contributors: Aoki, T.; Hino, M.; Koh, K.; Kyushiki, M.; Kishimoto, H.; Arakawa, Y.; Hanada, R.; Kawashima, H.; Kurihara, J.; Shimojo, N. et al.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Biology of Blood and Marrow Transplantation
2016 | Journal article
DOI: 10.1016/j.bbmt.2015.12.025
EID:

2-s2.0-84960477430

Part of ISSN: 15236536 10838791
Contributors: Aoki, T.; Koh, K.; Kawano, Y.; Mori, M.; Arakawa, Y.; Kato, M.; Hanada, R.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia

[Rinshō ketsueki] The Japanese journal of clinical hematology
2014 | Journal article
EID:

2-s2.0-84925345079

Part of ISSN: 04851439
Contributors: Arakawa, Y.; Koh, K.; Aoki, T.; Kubota, Y.; Oyama, R.; Mori, M.; Hayashi, M.; Hanada, R.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Live vaccines in hematopoietic stem cell transplant recipients

[Rinsho ketsueki] The Japanese journal of clinical hematology
2014 | Journal article
EID:

2-s2.0-85028679122

Part of ISSN: 04851439
Contributors: Koh, K.; Aoki, T.
Source: Self-asserted source
Takahiro Aoki via Scopus - Elsevier
grade
Preferred source (of 2)‎

Peer review (11 reviews for 7 publications/grants)

Review activity for Acta haematologica. (1)
Review activity for Annals of hematology. (1)
Review activity for Cancer immunology, immunotherapy. (1)
Review activity for International immunopharmacology. (1)
Review activity for Pediatric blood & cancer. (1)
Review activity for Pediatrics international. (5)
Review activity for The Lancet. (1)
How many people are using ORCID?